Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 10,650
-250 (-2.29%)
At close: Feb 27, 2026
-25.00% (1Y)
| Market Cap | 128.00B |
| Revenue (ttm) | 14.41B |
| Net Income (ttm) | 15.76B |
| Shares Out | 12.02M |
| EPS (ttm) | 262.37 |
| PE Ratio | 40.59 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 154,545 |
| Average Volume | 160,304 |
| Open | 10,900 |
| Previous Close | 10,900 |
| Day's Range | 10,600 - 10,900 |
| 52-Week Range | 10,550 - 20,000 |
| Beta | 0.84 |
| RSI | 36.25 |
| Earnings Date | Feb 27, 2026 |